Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% response rates in rare neuroendocrine tumors, offering a potential advance over ...

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

The team recommended PRRT (Peptide Receptor Radionuclide Therapy), a therapy that delivers radiation directly to cancer cells ...

Danielle Walker, 36, plans to undergo immunotherapy treatment in Germany which costs £35,000 a course :: The family has ...

Neuroendocrine cancer articles from across Nature Portfolio Neuroendocrine cancer (also known as NETs) is a cancer type that arises from cells of the neuroendocrine system (cells that release ...

Kim Kardashian posted an emotional tribute to Lindsay May Palevsky, who died in November 2024 following a years-long battle ...

Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...

The pituitary gland, located at the base of the brain, secretes hormones that control vital bodily functions and also regulates the activity of other ...

Kim Kardashian penned a tribute to Lindsay May Palevsky, a core member of her 'Lifers' group of childhood friends who died of ...

ESTEVE has entered into an agreement with Sanofi to acquire Caprelsa® (vandetanib) rights in more than 50 countries, a ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, explains how the company partners with patient advocacy groups to identify unmet needs and prioritize patient-centered benefits in the ...